Benzinga··PrnewswireCitius Pharma Posts Inaugural Revenue on LYMPHIR™ Commercial Launch
Citius Pharma reports first revenue of $3.9M from LYMPHIR™ launch, raises $20.9M to support growth and advance pipeline candidates.
CTXRCTORorphan drugimmunotherapy